1. Home
  2. AIZ vs RGEN Comparison

AIZ vs RGEN Comparison

Compare AIZ & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIZ
  • RGEN
  • Stock Information
  • Founded
  • AIZ 1892
  • RGEN 1981
  • Country
  • AIZ United States
  • RGEN United States
  • Employees
  • AIZ N/A
  • RGEN N/A
  • Industry
  • AIZ Property-Casualty Insurers
  • RGEN Medical/Dental Instruments
  • Sector
  • AIZ Finance
  • RGEN Health Care
  • Exchange
  • AIZ Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • AIZ 10.1B
  • RGEN 8.0B
  • IPO Year
  • AIZ N/A
  • RGEN N/A
  • Fundamental
  • Price
  • AIZ $193.47
  • RGEN $127.47
  • Analyst Decision
  • AIZ Strong Buy
  • RGEN Buy
  • Analyst Count
  • AIZ 6
  • RGEN 12
  • Target Price
  • AIZ $231.33
  • RGEN $170.40
  • AVG Volume (30 Days)
  • AIZ 409.6K
  • RGEN 694.0K
  • Earning Date
  • AIZ 08-05-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • AIZ 1.65%
  • RGEN N/A
  • EPS Growth
  • AIZ N/A
  • RGEN N/A
  • EPS
  • AIZ 12.82
  • RGEN N/A
  • Revenue
  • AIZ $12,071,400,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • AIZ $6.89
  • RGEN $13.93
  • Revenue Next Year
  • AIZ $4.49
  • RGEN $14.35
  • P/E Ratio
  • AIZ $15.09
  • RGEN N/A
  • Revenue Growth
  • AIZ 6.18
  • RGEN 4.88
  • 52 Week Low
  • AIZ $160.12
  • RGEN $102.97
  • 52 Week High
  • AIZ $230.55
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • AIZ 44.45
  • RGEN 54.11
  • Support Level
  • AIZ $190.64
  • RGEN $121.44
  • Resistance Level
  • AIZ $200.11
  • RGEN $131.43
  • Average True Range (ATR)
  • AIZ 3.49
  • RGEN 4.47
  • MACD
  • AIZ -0.49
  • RGEN 0.61
  • Stochastic Oscillator
  • AIZ 29.40
  • RGEN 74.57

About AIZ Assurant Inc.

Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: